Scott Marshall - Concepedia

Author

Scott Marshall

Also Known As

Marshall, Scott, R. Scott Marshall, S Marshall, S. F. Marshall, S. Marshall, S.F. Marshall, SCOTT MARSHALL, Scott F. Marshall, Scott Marshall, Sunny Chapel

Publications

1.6K

Citations

H-Index

100

Concepts

All Affiliations

Pfizer (United Kingdom)Pfizer (United States)Portland State University Uppsala University University of Pittsburgh

About

Scott Marshall is an author at Pfizer (United Kingdom) specializing in medicine, accounting, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Business	4	4	246
2	Engineering	4	4	139
3	Management	2	2	102
4	Education	1	1	23
5	Health Sciences	1	1	43

Scott Marshall

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The ‘ReSpECT’ Study J Neuberger, R.D. Mamelok, P. Neuhaus, American Journal of Transplantation	2008	289
Model‐Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives Scott Marshall, Rajanikanth Madabushi, Efthymios Manolis, CPT Pharmacometrics & Systems Pharmacology Preclinical TherapeuticsFuture PerspectivesUs FoodPre-clinical PharmacologyModel-informed Drug Discovery	2018	119
Evolution of corporate reporting: From stand-alone corporate social responsibility reporting to integrated reporting Kathleen Hertz Rupley, Darrell Brown, Scott Marshall Research in Accounting Regulation Integrated ReportingAccountingCorporate ReportingBusinessCorporate Social Responsibility	2017	108
A population pharmacokinetic analysis of sildenafil citrate in patients with erectile dysfunction Peter A. Milligan, Scott Marshall, Mats O. Karlsson British Journal of Clinical Pharmacology	2002	65
THE IMPACT OF VOLUNTARY ENVIRONMENTAL DISCLOSURE QUALITY ON FIRM VALUE. Scott Marshall, Darrell Brown, Marlene Plumlee Academy of Management Proceedings Environmental PerformanceEngineeringEnvironmental Impact AssessmentVoluntary Environmental DisclosureSocial Accounting	2009	60
A Quantitative Approach for Making Go/No-Go Decisions in Drug Development Christy Chuang‐Stein, Simon Kirby, Jonathan French, Drug Information Journal Drug RepositioningGo/no-go DecisionsDrug DesignMedicineDrug Trial	2011	57
Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment Elena Soto, Satoshi Shoji, Chieko Muto, British Journal of Clinical Pharmacology	2013	43
Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis Kushang V. Patel, Robert R. Allen, Laurie B. Burke, Pain Pain TherapyPain DisordersPain MedicineNeuromodulation TherapiesNeuropathic Pain	2018	43
The Impact of Voluntary Environmental Disclosure Quality on Firm Value Marlene Plumlee, Darrell Brown, Scott Marshall SSRN Electronic Journal Environmental PerformanceEngineeringVoluntary Environmental DisclosuresIntegrated ReportingEnvironmental Impact Assessment	2008	42
Governance, media and the quality of environmental disclosure Kathleen Hertz Rupley, Darrell Brown, Scott Marshall Journal of Accounting and Public Policy Environmental DisclosureMedium OwnershipAccountingGovernment TransparencyEnvironmental Management	2012	40

Page 1